Special Seminar: A Genetic Toolset for Investigating Glio-vascular Interactions
Hajime Hirase, Ph.D.
Professor
Center for Translational Medicine
University of Copenhagen
Special Seminar
A Genetic Toolset for Investigating Glio-vascular Interactions
Date: Oct. 10, 2024
Time: 11 a.m. to 12 p.m.
About this Seminar
Studying blood microcirculation is crucial for understanding vascular diseases. Blood flow is currently imaged following invasive administration of fluorescent dyes that disappear within one hour from injection. Dr. Hirase and his team took three new molecular genetic approaches for the longitudinal study of vasculature. Liver-secreted albumin is the most abundant protein in blood plasma and cerebrospinal fluid. They have developed liver-targeting adeno-associated viral vectors (AAVs) that express fluorescent protein-tagged albumin to visualize blood plasma in mice following a single systemic injection. While this approach is versatile for imaging in adult mice, the dilution of the episomal AAV genome in the rapidly growing liver in infants precludes chronic neonatal imaging. Therefore, they have established a virally induced CRISPR/Cas9-based knock-in of fluorescent albumin. They constructed an AAV that includes ~1 kb homologous arms around Alb exon 14 to express Alb-mNeonGreen instead of Alb. Systemic injection of this AAV with AAV-CMV-Cas9 in postnatal day 3 mice resulted in two-photon visualization of the cerebral cortex vasculature within ten days and persistent expression of Alb-mNeonGreen for at least the next three months. As an alternative approach, they have used CRISPR/Cas9 genome editing to generate a mouse in which the bright red fluorescent protein mScarlet is knocked into Alb exon 14. This mouse line is also equipped with a signal amplification mechanism allowing for investigations in glio-vascular interactions. These three new plasma labeling approaches are expected to provide powerful means for micro- and macroscopic imaging of murine vasculature.
You May Also Be Interested In...
-
Home Item
Exercise, the Fountain of Youth? , homeOct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture
-
Home Item
Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , homeOct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.
-
Home Item
Mapping Different Excitatory and Inhibitory Input Types onto Single Cortical Pyramidal Neurons , homeOct. 30, 2026, 11:00 a.m. | Elly Nedivi, Ph.D., William R. (1964) & Linda R. Young Professor of Neuroscience, The Picower Institute for Learning & Memory, Departments of Brain and Cognitive Sciences, and Biology, Massachusetts Institute of Technology | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Neurobiology Research
-
Home Item
Drug Discovery in the Next Decade: From Genome Medicine to Clinical Trial in a Dish , homeNov. 5, 2026, 5:30 p.m. (Reception at 5 p.m.) | Joseph Wu, M.D., Ph.D., Professor and Director, Stanford Cardiovascular Institute, Stanford University School of Medicine | Maury Strauss Distinguished Public Lecture
-
Home Item
Presenting Therapeutic Peptides Using Synthetic Polymers , homeNov. 13, 2026, 11:00 a.m. | Rachel A. Letteri, Ph.D., Associate Professor, Departments of Chemical Engineering, University of Virginia | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research
-
Home Item
The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , homeDec. 11, 2026, 11:00 a.m. | Paule V. Joseph, Ph.D., MBA, Lasker Clinical Research Scholar, NIH Distinguished Scholar, Acting Chief, Section of Sensory Science and Metabolism Unit, NIDCD; Co-Director, National Smell and Taste Center; Attending Nurse Practitioner, Division of Intramural Clinical and Biological Research; National Institute on Alcohol Abuse and Alcoholism, National Institute on Deafness and Other Communication Disorders | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research